A PHASE I RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A LIVE-ATTENUATED TETRAVALENT DENGUE VACCINE (V181) IN FLAVIVIRUS-NAIVE AND FLAVIVIRUS- EXPERIENCED HEALTHY ADULTS

被引：0

作者：

Russell, Kevin ^{[1
]}

Rupp, Richard ^{[2
]}

Morales-Ramirez, Javier ^{[3
]}

Diaz-Perez, Clemente ^{[4
]}

Andrews, Charles ^{[5
]}

Davis, Matthew ^{[6
]}

Lee, Andrew ^{[1
]}

Finn, Tyler ^{[1
]}

Russell, Amy Falk ^{[1
]}

Schaller, Margaret ^{[1
]}

Martin, Jason ^{[1
]}

Hyatt, Donna ^{[1
]}

Gozlan-Kelner, Sabrina ^{[1
]}

Stek, Jon ^{[1
]}

Coller, Beth-Ann ^{[1
]}

机构：

[1] Merck & Co Inc, Kenilworth, NJ USA

[2] Univ TX Med Branch, Galveston, TX USA

[3] Ashford Presbyterian Community Hosp, San Juan, PR USA

[4] Univ Puerto Rico, San Juan, PR 00936 USA

[5] Diagnost Res Grp, San Antonio, TX USA

[6] Rochester Clin Res, Rochester, NY USA

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2019年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

199

引用

页码：60 / 60

页数：1

共 50 条

[41] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
Qian Zhao
Hongzhong Liu
Zhenlei Wang
Teng Wang
Cheng Cui
Huanhuan Wang
Lili Li
Wen Zhong
Ji Jiang
Kai Dong
Shuai Chen
Chunyan Jin
Pei Hu
Advances in Therapy, 2023, 40 : 3186 - 3198
[42] SAFETY AND IMMUNOGENICITY OF AGS-V, A MOSQUITO SALIVA PEPTIDE VACCINE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 TRIAL
Manning, Jessica E.
Kamhawi, Shaden
Oliveira, Fabiano
Coutinho-Abreu, Iliano V.
Meneses, Claudio
Baus, Holly Ann
Han, Alison
Czajkowski, Lindsay
Donaldson, Amanda
Athota, Rani
Reed, Susan
Bristol, Tyler
Rosas, Luz Angela
Fernandez, Ana
Pleguezuelos, Olga
Stoloff, Gregory
Valenzuela, Jesus
Memoli, Matt
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 365 - 365
[43] SAFETY AND IMMUNOGENICITY OF AGS-V, A MOSQUITO SALIVA PEPTIDE VACCINE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 TRIAL
Manning, Jessica
Oliveira, Fabiano
Coutinho-Abreu, Iliano
Herbert, Samantha
Meneses, Claudio
Kamhawi, Shaden
Baus, Holly
Han, Alison
Czajkowski, Lindsay
Rosas, Luz
Cervantes-Medina, Adriana
Athota, Rani
Reed, Susan
Fernandez, Ana
Pleguezuelos, Olga
Stoloff, Gregory
Valenzuela, Jesus
Memoli, Matthew
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 213 - 213
[44] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants
Li, Yunfei
Zhang, Hua
Pandya, Hitesh
Miao, Liyan
Reid, Fred
Jimenez, Eulalia
Sadiq, Muhammad Waqas
Moate, Rachel
Lei, Alejhandra
Zhou, Xiao-Hong
Kell, Chris
Ding, Junjie
Zhang, Guanlin
Zhao, Lina
Ge, Xiaoyun
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (06): : 665 - 671
[45] A Dose-Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial
Bhandari, Nita
Sharma, Pooja
Taneja, Sunita
Kumar, Tivendra
Rongsen-Chandola, Temsunaro
Appaiahgari, Mohan Babu
Mishra, Arpita
Singh, Shakti
Vrati, Sudhanshu
JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (03): : 421 - 429
[46] Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial
Liao, Yuyi
Li, Yuan
Pei, Rongjuan
Fang, Xin
Zeng, Peiyu
Fan, Renfeng
Ou, Zhiqiang
Deng, Jinglong
Zhou, Jian
Guan, Wuxiang
Min, Yuanqin
Deng, Fei
Peng, Hua
Zhang, Zheng
Feng, Chunyan
Xin, Baobao
He, Jianfeng
Hu, Zhongyu
Zhang, Jikai
EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1589 - 1597
[47] Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial
Shu, Ya-Jun
He, Jian-Feng
Pei, Rong-Juan
He, Peng
Huang, Zhu-Hang
Chen, Shao-Min
Ou, Zhi-Qiang
Deng, Jing-Long
Zeng, Pei-Yu
Zhou, Jian
Min, Yuan-Qin
Deng, Fei
Peng, Hua
Zhang, Zheng
Wang, Bo
Xu, Zhong-Hui
Guan, Wu-Xiang
Hu, Zhong-Yu
Zhang, Ji-Kai
CHINESE MEDICAL JOURNAL, 2021, 134 (16) : 1967 - 1976
[48] Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial
Shu Ya-Jun
He Jian-Feng
Pei Rong-Juan
He Peng
Huang Zhu-Hang
Chen Shao-Min
Ou Zhi-Qiang
Deng Jing-Long
Zeng Pei-Yu
Zhou Jian
Min Yuan-Qin
Deng Fei
Peng Hua
Zhang Zheng
Wang Bo
Xu Zhong-Hui
Guan Wu-Xiang
Hu Zhong-Yu
Zhang Ji-Kai
中华医学杂志英文版, 2021, 134 (16) : 1967 - 1976
[49] Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial
Launay, Odile
Sadorge, Christine
Jolly, Nathalie
Poirier, Beatrice
Bechet, Stephane
van der Vliet, Diane
Seffer, Valerie
Fenner, Nicola
Dowling, Kelly
Giemza, Raphaela
Johnson, Julie
Ndiaye, Anna
Vray, Muriel
Sansonetti, Philippe
Morand, Philippe
Poyart, Claire
Lewis, David
Gougeon, Marie-Lise
VACCINE, 2009, 27 (08) : 1184 - 1191
[50] Randomized, double-blind, placebo-controlled, phase I study of the safety and pharmacokinetics of namilumab in healthy Japanese and Caucasian men
Tanaka, Shingo
Harada, Sayaka
Hiramatsu, Naoto
Nakaya, Ryou
Kawamura, Masaki
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (11) : 507 - 517

← 1 2 3 4 5 →